IUPAC Name: [5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Molecular Formula: C10H13FN5O7P
Molecular Weight: 365.21 g/mol
Classification Code: Antimetabolites; Antimetabolites, antineoplastic; Antineoplastic; Antineoplastic Agents; Drug / Therapeutic Agent; Human Data; Immunologic Factors; Immunosuppressive agents; Noxae
Product Categories: Active Pharmaceutical Ingredients; Antineoplastics; Antineoplastic; API
XLogP3: -3.1
H-Bond Donor: 5
H-Bond Acceptor: 12
Surface Tension: 130.7 dyne/cm
Density: 2.39 g/cm3
Flash Point: 476.4 °C
Enthalpy of Vaporization: 131.58 kJ/mol
Boiling Point: 864.2 °C at 760 mmHg
Vapour Pressure of Fludarabine phosphate (CAS NO.75607-67-9): 7.38E-32 mmHg at 25 °C
Fludarabine phosphate (CAS NO.75607-67-9) is a chemotherapy drug used in the treatment of hematological malignancies. It is highly effective in the treatment of chronic lymphocytic leukemia.
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | intravenous | 18750mg/kg/5D (18750mg/kg) | BRAIN AND COVERINGS: ENCEPHALITIS SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE | Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986. |
man | TDLo | intravenous | 11655mg/kg/5D (11655mg/kg) | SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Cancer Treatment Reports. Vol. 70, Pg. 1449, 1986. |
man | TDLo | intravenous | 17760mg/kg/5D (17760mg/kg) | BRAIN AND COVERINGS: DEMYELINATION BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" BEHAVIORAL: COMA | Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986. |
mouse | LD50 | intravenous | 1236mg/kg (1236mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | National Technical Information Service. Vol. PB83-195685, |
women | LDLo | intravenous | 14245mg/kg/5D (14245mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER: EYE BEHAVIORAL: EXCITEMENT SKIN AND APPENDAGES (SKIN): SWEATING: OTHER | Cancer Treatment Reports. Vol. 70, Pg. 1449, 1986. |
women | TDLo | intravenous | 23125mg/kg/5D (23125mg/kg) | BRAIN AND COVERINGS: ENCEPHALITIS SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Cancer Treatment Reports. Vol. 70, Pg. 1225, 1986 |
Fludarabine phosphate (CAS NO.75607-67-9), its Synonyms are Fludarabine monophosphate ; 2-Fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine ; 2-Fluoro-ARA AMP ; 2-Fluoroadenine arabinoside 5'-monophosphate ; 9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate ; 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate) ; 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate ; Fludara ; 9H-Purin-6-amine, 2-fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)- .
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View